Prognostic Significance of 18F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study

1Department of Nuclear Medicine, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea; 2Department of Radiology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea; 3Department of Radiology, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea; 4Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; 5Department of Nuclear Medicine, Kyung Hee University Hospital, School of Medicine, Kyung Hee University, Seoul, Korea; 6Department of Nuclear Medicine, Korea University Guro Hospital, Seoul, Korea; 7Department of Nuclear Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea; 8Department of Nuclear Medicine, National Cancer Center Research Institute and Hospital, Gyeonggi-do, Korea; 9Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea; 10Department of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; 11Department of Radiology, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea; and 12Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Korea